Innovative Long-Acting Bisoprolol Patch: Synergistic Ion-Pair Skin Adsorption for Drug Delivery Control Coupled with Dynamic Modulation of Penetration Enhancers
- 29 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (12) , 6290-6301
Abstract
This study aims to develop a sustained release patch for bisoprolol (BSP) to address the issue of blood pressure fluctuations caused by traditional dosing methods, ensuring continuous drug release and efficient utilization. Long-chain saturated fatty acids (C6-C12) were chosen as counterions to precisely control BSP's permeation rate in the patch formulation, and the ion-pairing strategy's mechanism in drug delivery was thoroughly investigated. Molecular docking results revealed significant differences in the adsorption capacities of different ion pairs in the stratum corneum (SC) and epidermis, directly influencing their residence times and thereby regulating BSP's passive diffusion rate. Particularly, the BSP-C10 ion pair successfully reduced BSP's permeation rate to one-third of its baseline. To enhance drug delivery efficiency and reduce costs, chemical permeation enhancers (CPEs) are typically added to sustained release patches. In contrast to traditional static analyses based on cumulative permeation, this study utilized ATR-FTIR dynamic detection of isopropyl myristate (IPM) as a preferred enhancer, studying its disruptive effects on the skin barrier during drug delivery. The study observed that during drug delivery, the interaction between IPM and skin lipids follows a U-shaped trend: initially increasing, then decreasing, with the peak occurring at 10 h. Similarly, the drug delivery rate displays a comparable pattern. The addition of IPM as CPE increased the patch utilization rate from 39.8 +/- 4.31 to 79.8 +/- 7.27%. This strategy aims to rapidly reduce blood pressure in the initial phase with subsequent weakening of IPM disruption, allowing the ion-pairing strategy to dominate drug delivery control and maintain stable long-term therapeutic effects. Pharmacokinetic studies demonstrated that the newly developed BSP sustained release patch maintains stable blood drug concentrations, reduces burst release effects, increases bioavailability to 84.679%, doubles MRT0-t , halves C max, and significantly reduces the occurrence of blood pressure fluctuations.Keywords
This publication has 38 references indexed in Scilit:
- Water-compatible cross-linked pyrrolidone acrylate pressure-sensitive adhesives with persistent adhesion for transdermal delivery: Synergistic effect of hydrogen bonding and electrostatic forceActa Biomaterialia, 2024
- Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2020
- Dual-directional regulation of drug permeating amount by combining the technique of ion-pair complexation with chemical enhancers for the synchronous permeation of indapamide and bisoprolol in their compound patch through rabbit skinEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Effective use of transdermal drug delivery in childrenAdvanced Drug Delivery Reviews, 2014
- Breaching the skin barrier — Insights from molecular simulation of model membranesAdvanced Drug Delivery Reviews, 2013
- Recent advances in transdermal drug deliveryArchives of Pharmacal Research, 2010
- Physicochemical characterization and drug release properties of Eudragit® E PO/Eudragit® L 100-55 interpolyelectrolyte complexesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Effect of Various Enhancers on Transdermal Penetration of Indomethacin and Urea, and Relationship between Penetration Parameters and Enhancement FactorsJournal of Pharmaceutical Sciences, 1995
- Effects of Treatment on Morbidity in HypertensionJAMA, 1967